Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | aminophenazone | 54766 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | aminophenazone | 54766 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | aminophenazone | 54766 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | aminophenazone | 54766 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | aminophenazone | 54766 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | aminophenazone | 54766 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | aminophenazone | 54766 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | aminophenazone | 54766 | drug-path |
| Hedgehog signaling pathway | R-HSA-5358351 | map04340 | aminophenazone | 54766 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | aminophenazone | 54766 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | levobunolol | 39468 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | levobunolol | 39468 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | levobunolol | 39468 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | levobunolol | 39468 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | levobunolol | 39468 | drug-path |
| Asthma | R-HSA-444620 | map05310 | levobunolol | 39468 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | levobunolol | 39468 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | levobunolol | 39468 | drug-path |
| Shigellosis | 0 | map05131 | levobunolol | 39468 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | levobunolol | 39468 | drug-path |